Ongoing Research at the Comprehensive Pulmonary Hypertension Program

Although there is still no cure for pulmonary hypertension (PH), the UPMC Comprehensive Pulmonary Hypertension Program actively participates in many clinical trials. These allow patients to obtain experimental therapies, as well as contribute to the advancement of knowledge and treatment of PH.

Without research, we would not have the 12 FDA-approved medical treatments for pulmonary arterial hypertension today.

During your visit, a doctor, nurse practitioner, or nurse may ask you if you're interested in hearing more about research opportunities. Whether or not you decide to participate is entirely up to you.

Pulmonary Hypertension and Heart Failure Research Registry

We are enrolling patients with a diagnosis of PH and heart failure in a research registry. Blood-work is collected at enrollment and medical records will be reviewed by researchers.

The registry also allows researchers to contact patients for possible participation in future research studies directed at the study of PH and/or HF diseases.

Acute Inhaled Nitrite Study

UPMC is seeking 30 patients, with a confirmed diagnosis of PH and who meet all inclusion/exclusion criteria, to enroll in the study which will entail a single right heart catheterization.

Participants are followed on a routine basis in the UPMC Heart and Vascular Institute or Comprehensive Lung Center.

Initial screening evaluations include:

  • Physical exam
  • Medical history
  • Clinical laboratory assessments

People that meet all eligibility criteria will be compensated.

Chronic Inhaled Nitrite Studies

PAH Group I patients that have completed the acute inhaled nitrite study may be eligible for the 16-week chronic AIR001 study.

Participants will be randomized to one of three study dosage arms:

  • 80mg daily
  • 46mg four times a day
  • 80mg four times a day

Participants must be:

  • 18 years or older.
  • Available for a screening visit to determine eligibility to participate.
  • Able to make six visits to UPMC Presbyterian during a 16 week period.

At the end of the 16 weeks, you may be eligible to participate in the long term extension portion of this study.

If you qualify to participate, you will be compensated $50 for each completed study visit.

Contact Information

For more information about enrollment in any of these registries or studies, or for a full list of other studies, call

Academic Resources


UPMC | Affiliated with the University of Pittsburgh Schools of the Health Sciences | Supplemental content provided by Healthwise, Incorporated. To learn more, visit

For help in finding a doctor or health service that suits your needs, call the UPMC Referral Service at 412-647-UPMC (8762) or 1-800-533-UPMC (8762). Select option 1.

UPMC is an equal opportunity employer. UPMC policy prohibits discrimination or harassment on the basis of race, color, religion, ancestry, national origin, age, sex, genetics, sexual orientation, gender identity, marital status, familial status, disability, veteran status, or any other legally protected group status. Further, UPMC will continue to support and promote equal employment opportunity, human dignity, and racial, ethnic, and cultural diversity. This policy applies to admissions, employment, and access to and treatment in UPMC programs and activities. This commitment is made by UPMC in accordance with federal, state, and/or local laws and regulations.

Medical information made available on is not intended to be used as a substitute for professional medical advice, diagnosis, or treatment. You should not rely entirely on this information for your health care needs. Ask your own doctor or health care provider any specific medical questions that you have. Further, is not a tool to be used in the case of an emergency. If an emergency arises, you should seek appropriate emergency medical services.

Pittsburgh, PA, USA |